The incidence and prevalence of cardiovascular diseases in gout: a systematic review and meta-analysis
Open Access
- 13 May 2021
- journal article
- review article
- Published by Springer Nature in Rheumatology International
- Vol. 41 (7) , 1209-1219
Abstract
The aims of this systematic review and meta-analysis were to describe prevalence of cardiovascular disease in gout, compare these results with non-gout controls and consider whether there were differences according to geography. PubMed, Scopus and Web of Science were systematically searched for studies reporting prevalence of any cardiovascular disease in a gout population. Studies with non-representative sampling, where a cohort had been used in another study, small sample size (< 100) and where gout could not be distinguished from other rheumatic conditions were excluded, as were reviews, editorials and comments. Where possible meta-analysis was performed using random-effect models. Twenty-six studies comprising 949,773 gout patients were included in the review. Pooled prevalence estimates were calculated for five cardiovascular diseases: myocardial infarction (2.8%; 95% confidence interval (CI)s 1.6, 5.0), heart failure (8.7%; 95% CI 2.9, 23.8), venous thromboembolism (2.1%; 95% CI 1.2, 3.4), cerebrovascular accident (4.3%; 95% CI 1.8, 9.7) and hypertension (63.9%; 95% CI 24.5, 90.6). Sixteen studies reported comparisons with non-gout controls, illustrating an increased risk in the gout group across all cardiovascular diseases. There were no identifiable reliable patterns when analysing the results by country. Cardiovascular diseases are more prevalent in patients with gout and should prompt vigilance from clinicians to the need to assess and stratify cardiovascular risk. Future research is needed to investigate the link between gout, hyperuricaemia and increased cardiovascular risk and also to establish a more thorough picture of prevalence for less common cardiovascular diseases.Keywords
This publication has 60 references indexed in Scilit:
- Gout and subsequent increased risk of cardiovascular mortality in non-diabetics aged 50 and above: a population-based cohort study in TaiwanBMC Cardiovascular Disorders, 2012
- Risk of myocardial infarction among patients with gout: a nationwide population-based studyRheumatology, 2012
- Ambulatory arterial stiffness indices and target organ damage in hypertensionBMC Cardiovascular Disorders, 2012
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular RiskClinical Journal of the American Society of Nephrology, 2010
- Hyperuricemia and coronary heart disease: A systematic review and meta‐analysisArthritis Care & Research, 2010
- Hyperuricemia and risk of stroke: A systematic review and meta‐analysisArthritis Care & Research, 2009
- Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin systemJournal Of Hypertension, 2008
- Relationship between hyperuricemia and metabolic syndromeJournal of Zhejiang University-SCIENCE B, 2007
- Uric Acid Is a Risk Factor for Myocardial Infarction and StrokeStroke, 2006
- Severity of gouty arthritis is associated with Q-wave myocardial infarction: a large-scale, cross-sectional studyClinical Rheumatology, 2006